News Conference News THT 2023 Meta-analysis Hints at Survival Benefit With LAP Monitoring in HFrEF Shelley Wood March 22, 2023
News Conference News THT 2023 REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests Yael L. Maxwell March 22, 2023
News Conference News THT 2023 Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF Todd Neale March 22, 2023
News Conference News THT 2023 Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF Shelley Wood March 21, 2023
News Conference News THT 2023 Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF Todd Neale March 21, 2023
News Conference News THT 2023 Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry Caitlin E. Cox March 21, 2023
News Conference News THT 2023 TEER or VAD/Transplant in the Advanced HF Patient With MR? Shelley Wood March 20, 2023
News Conference News THT 2023 PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate Todd Neale March 20, 2023
News Conference News ACC 2023 Diabetic Patients in Middle East, Africa Overburdened by ASCVD Michael O'Riordan March 14, 2023
News Conference News ACC 2023 IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF L.A. McKeown March 14, 2023
News Conference News ACC 2023 CRP More Predictive of Future Events Than LDL in Statin-Treated Patients Caitlin E. Cox March 14, 2023
News Conference News ACC 2023 Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR Michael O'Riordan March 13, 2023
News Conference News ACC 2023 UK Mini Mitral: No Clear Win for Minimally Invasive MV Repair Todd Neale March 13, 2023
News Conference News ACC 2023 Tailored Alerts Up High-Intensity Statin Prescribing: PCDS Statin Yael L. Maxwell March 13, 2023
News Conference News ACC 2023 Real-world Primary MR TEER Outcomes Carry a Reminder: Do Better Shelley Wood March 10, 2023
News Conference News ACC 2023 STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients L.A. McKeown March 10, 2023
News Conference News ACC 2023 Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study Todd Neale March 10, 2023
News Conference News ACC 2023 MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis Michael O'Riordan March 10, 2023
News Conference News ACC 2023 ‘Causal AI’ May Help Guide Specific Actions to Reduce CVD Risk Caitlin E. Cox March 10, 2023
News Conference News ACC 2023 How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA Todd Neale March 09, 2023